No Prescription |
 |
 | ||
|
Coversyl Coversyl Plus |
|
| ||
No Prescription » Prescription Drugs 5 » Coversyl Coversyl Plus Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Coversyl Tablets is indicated in patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or nonfatal myocardial Infarction. Coversyl Tablets can be used with conventional treatment for management of coronary artery disease such as antiplatelet antihypertensive or lipid lowering therapy. Hypertension: Coversyl Tablets is indicated for the treatment of patients with essential hypertension. Coversyl Tablets may be used alone or given with other classes of antihypertensives especially thiazide diuretics. Buy Coversyl Coversyl Plus and other Prescription Drugs 5 products online at Medstore. Buy Online at Medstore - Click Here!
About Coversyl Coversyl Plus: Product Type: Prescription Drugs 5 Coversyl Plus ( Corversyl Aceon Generic Perindopril & Indapamide ) Coversyl (Coversyl Plus Aceon Generic Perindopril) Coversyl Plus Aceon Generic Perindopril 5mg 30 Tablets 8mg 90(3 x 30) Tablets 4mg Coversyl Plus Aceon Generic Perindopril Coversyl
View more Prescription Drugs 5 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
